The Cancer Consortium-Nanostics: Advanced Machine Learning to Detect Prostate Cancer
The Cancer Consortium-Nanostics: Advanced Machine Learning to Detect Prostate Cancer
Nanostics’ core technology, ClarityDX, combines a sensitive extracellular vesicle detection platform with advanced machine learning to diagnose a disease from a simple blood test.